The company is in a severe liquidity crisis with a going concern warning, ongoing Nasdaq delisting risk, and a related-party asset sale that provides no cash to the parent. The dilutive convertible note structure (variable pricing with low floors) will continue to pressure the stock. Traders should expect further dilution and potential delisting if the bid price remains below $1.00 past October 6, 2026. Monitor for any definitive agreement on the Slil transaction or additional emergency financing.
Price Chart
Executive Summary
IM Cannabis Corp. (IMCC) reported a severe deterioration in its H1 2026 financials, with revenue declining 35% YoY to $16.3M and net loss widening to $6.9M from a near-breakeven position. The company's cash position has dwindled to $1.6M, and it has negative working capital of $13.1M, with substantial doubt about its ability to continue as a going concern. The filing also details a related-party transaction to sell its European assets to the CEO's entity, which is structured as a financial hardship transaction with no cash consideration, and ongoing dilutive convertible note financing that has already resulted in massive shareholder dilution (shares outstanding more than doubled to 16.3M).
Key Facts
- Revenue for H1 2026 was $16.3M, down 35% from $25.2M in H1 2025.
- Net loss for H1 2026 was $6.9M, compared to a near-breakeven net loss of $19K in H1 2025.
- Cash and restricted cash totaled only $1.7M as of June 30, 2026, down from $3.3M at year-end 2025.
- Working capital deficit was $13.1M (current assets of $16.3M vs. current liabilities of $29.4M).
- Shareholders' deficit was $5.6M, and accumulated deficit reached $276.7M.
- The company has substantial doubt about its ability to continue as a going concern.
- Common shares outstanding more than doubled to 16.3M from 5.9M at year-end 2025, driven by convertible note conversions and warrant exercises.
- The company entered into a non-binding LOI to sell its European assets to the CEO's entity, with no cash consideration and assumption of $10.5M in liabilities.
- Nasdaq non-compliance for minimum bid price continues, with a cure period until October 6, 2026.
- The company has been raising capital through highly dilutive convertible notes with variable conversion prices and low floor prices.
Financial Impact
Revenue decline of $8.9M (35%) YoY; net loss increase of $6.8M; cash burn of $1.3M from operations in H1 2026; working capital deficit of $13.1M; total liabilities of $30.3M exceed total assets of $24.7M.
Risk Factors
- Nasdaq delisting risk if minimum bid price compliance is not regained by October 6, 2026.
- Going concern risk — cash position of $1.6M is insufficient to cover near-term liabilities.
- Massive ongoing dilution from convertible notes with variable conversion prices and low floor prices (as low as $0.02 per share).
- Related-party Slil transaction may not close or may be challenged by minority shareholders.
- Potential adverse impact from German regulatory changes requiring in-person physician consultations and banning mail-order cannabis flower distribution.
- Geopolitical risks from ongoing conflict in Israel impacting operations and supply chain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-004126 |
| Exhibit: exhibit_99-3.htm | 0001178913-26-004126 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | EFFECT | $1.19 | awaiting T+20 | — | $0.8700 (−26.89%) |
Oct 2, 2026 24d ago | 6-K | $1.94 | awaiting T+20 | — | $0.8700 (−55.15%) |
Sep 25, 2026 4w ago | 6-K | $2.48 $0.8400 | ▲ +66.13% | ▲ +66.10% | $0.8700 (+64.92%) |
Sep 24, 2026 4w ago | 424B5 | $3.18 $0.9250 | ▲ +70.91% | ▲ +70.49% | $0.8700 (+72.64%) |
Sep 24, 2026 4w ago | 6-K | $3.18 $0.9250 | ▲ +70.91% | ▲ +70.49% | $0.8700 (+72.64%) |
Sep 23, 2026 4w ago | 6-K | $2.91 $1.19 | ▼ −59.11% | ▼ −59.79% | $0.8700 (−70.10%) |
Aug 17, 2026 10w ago | 6-K | $0.1050 $0.0543 | ▼ −48.25% | ▼ −46.28% | $0.8700 (+728.57%) |
Aug 13, 2026 10w ago | Press Release | $3.66 $1.72 | ▲ +53.01% | ▲ +51.01% | $0.8700 (+76.23%) |
Aug 13, 2026 10w ago | 6-K | $3.66 $1.72 | ▲ +53.01% | ▲ +51.01% | $0.8700 (+76.23%) |
Jul 27, 2026 13w ago | 6-K | $0.1088 $0.1088 | · 0.00% | ▼ −3.38% | $0.8700 (+699.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers